Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

ENETS Abstract Search

#4536 Follow-up is not justified in patients with typical lung carcinoids treated with curative intent

Introduction: Typical carcinoids (TC) are well-differentiated neuroendocrine neoplasms of the lung with generally favourable prognosis. Recurrence is rare in TC patients treated with curative intent, yet current ENETS guidelines recommend extensive follow-up, including regular and long-term imaging.

Conference:

Presenting Author: Lau T

Authors: Lau T, Soldath P, Rewitz K, Jepsen P, Knigge U,

Keywords: typical carcinoid, lung nen, follow-up programme,

#4202 Preliminary experience with a new institutional dedicated neuroendocrine team in a tertiary

Introduction: Due to the complexity of neuroendocrine neoplasm (NEN) management, a multidisciplinary approach is strongly encouraged. At our institution, tertiary care center, a NEN Team was established in January 2021.

Conference:

Presenting Author: Smiroldo V

Authors: Smiroldo V, Bollina R, de Nucci G, Della Torre S,

Keywords: tertiary care center, multidisciplinary, NEN team,

#3786 Overview of screening and surveillance practices for MEN1-related pancreatic neuroendocrine neoplasms in ENETS CoEs – An ENETS MEN1 Task Force Questionnaire Study

Introduction: The 2012 MEN1 Clinical Practice Guidelines were based on expert opinion with limited evidence, leaving room for interpretation and variation in practices.

Conference:

Presenting Author:

Authors: Pieterman C, Kaltsas G, Valk G, On Behalf of the Enets Men1 Task Force N,

Keywords: men1, screening, surveillance, PanNEN, ENETS CoE, Questionnaire,

#3438 Risk factors for complications after surgery for pancreatic neuroendocrine tumors

Introduction: Surgical resection is the only potentially curative treatment for pancreatic neuroendocrine tumors (pNETs). The choice for the type of procedure is influenced by the expected oncological benefit and the anticipated risk of procedure-specific complications.

Conference:

Presenting Author:

Authors: van Beek D, Takkenkamp T, de Kleine R, Walenkamp A, Klaase J,

Keywords: complications, pancreatic neuroendocrine tumor, surgery, Whipple, enucleation, distal pancreatectomy, postoperative pancreatic fistula, multiple endocrine neoplasia type 1, von Hippel-Lindau, Clavien-Dindo,

#2820 Efficacy of Peptide Receptor Radionuclide Therapy for Esthesioneuroblastoma

Introduction: Esthesioneuroblastoma (ENB) is a rare malignancy with limited therapeutic options when unresectable or metastatic. The overexpression of cell-surface somatostatin receptors in ENB is a potential molecular target making it amenable to peptide receptor radionuclide therapy (PRRT). High-level evidence supporting PRRT has been published for unresectable gastroenteropancreatic neuroendocrine tumours; however, data is limited for PRRT efficacy for ENB.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author: Kamel Hasan O

Authors: Kamel Hasan O, Ravi Kumar A, Kong G, Grozinsky-Glasberg S, Hicks R,

Keywords: esthesioneuroblastoma, peptide receptor radionuclide therapy, lutetium-177 dotatate,